1.Mermel, LA. Prevention of intravascular catheter–related infections (published correction appears in Ann Intern Med 2000;133:395). Ann Intern Med 2000;132:391–402.
2.Darouiche, RO, Raad, II, Heard, SO, et al.A comparison of two anti-microbial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999;340:1–8.
3.Maki, DG, Stolz, SM, Wheeler, S, Mermel, LA. Prevention of central venous catheter–related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257–266.
4.Fraenkel, D, Rickard, C, Thomas, P, Faoagali, J, George, N, Ware, R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006;34:668–675.
5.Marik, PE, Abraham, G, Careau, P, Varon, J, Fromm, RE JrThe ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999;27:1128–1131.
6.Bassetti, S, Hu, J, D'Agostino, RB JrSherertz, RJ. In vitro zones of inhibition of coated vascular catheters predict efficacy in preventing catheter infection with Staphylococcus aureus in vivo. Eur J Clin Microbiol Infect Dis 2000;19:612–617.
7.Raad, I, Darouiche, R, Hachem, R, Mansouri, M, Bodey, GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996;173:418–424.
8.Hanna, H, Bahna, P, Reitzel, R, et al.Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother 2006;50:3283–3288.
9.Yorganci, K, Krepel, C, Weigelt, JA, Edmiston, CE. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Eur J Clin Microbiol Infect Dis 2002;21:379–384.